v3 Template
A

Angiex Inc.

Biotechnology / Healthcare ~260 employees
Founded
--
Employees (Est.)
~260
13 leaders known
Total Funding
$31.0M
Funding Rounds
1
Last Funding
2025-11-17

About Angiex Inc.

Angiex is a biotech company focused on developing first-in-class Nuclear-Delivered Antibody-Drug Conjugates™ (ND-ADCs) to combat cancer lethality. Their mission is to make cancer a non-lethal disease by delivering safe and effective therapies to all.

Products & Services

AGX101:A lead Nuclear-Delivered Antibody-Drug Conjugate (ND-ADC) targeting TM4SF1 for the treatment of all solid tumors, soon heading to clinical trials.
Nuclear Delivery Platform™:A technology that delivers chemotherapeutic payloads to the nucleus of tumor cells and endothelial cells of tumor blood vessels, enabling drugs for solid cancers with high efficacy and therapeutic margin.
Pipeline of ND-ADCs:Additional Nuclear-Delivered Antibody-Drug Conjugates in discovery-stage development for solid cancers.

Specialties

Nuclear-Delivered Antibody-Drug Conjugates (ND-ADCs) Tumor Blood Vessel Biology Solid Cancer Therapies

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Equity Financing
T: -
FT: Equity Financing 		A: 31000000
MR: -
FA: $31 million
FAN: 31000000 		D: 2025-11-17
FD: 2025-11-17 		1 investors
Equity Financing Latest
2025-11-17
$31.0M
1 investor (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

I

Iain Dukes

Executive Chairman

LinkedIn (Pro only)
P

Paul Jaminet

Founder & CEO

LinkedIn (Pro only)
G

Glen Weiss

Chief Medical Officer

LinkedIn (Pro only)
J

Jeff Sacher

Chief Financial Officer

S

Shou-Ching Jaminet

Founder, Scientific Adviser

H

Hal Dvorak

Founder, SAB Chair

View 10 more team members with Pro

Unlock Full Team Directory

Recent News

Angiex Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Website
angiex.com
Industries
Biotechnology / Healthcare
Company Size
~260 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro